Le-Zong Chen Selected Research

Neoplasm Metastasis (Metastasis)

1/2020	Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97].
1/2017	Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer.
1/2016	Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression.
1/2016	Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Le-Zong Chen Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 01/2016
4	Stomach Neoplasms (Stomach Cancer) 06/2021 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2016
1	Esophageal Squamous Cell Carcinoma 10/2016
1	Pancreatitis 01/2016
1	Adenocarcinoma 01/2016

Drug/Important Bio-Agent (IBA)

3	Long Noncoding RNAIBA 06/2021 - 01/2016
2	nafamostatIBA 01/2020 - 01/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 01/2016
2	MelatoninIBA 10/2016 - 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 10/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Gemcitabine FDA Link 01/2016